Literature DB >> 12092483

Infections of intracardiac devices.

Adolf W Karchmer1, David L Longworth.   

Abstract

Intracardiac devices are increasingly used to correct hemodynamically dysfunctional valves and electrophysiologic abnormalities. These devices become infected at relatively low rates. Nevertheless, when these low rates are applied to widely used devices, significant numbers of infections result. Additionally, these infections have been associated with high degrees of morbidity and high mortality rates. This article reviews the epidemiology, microbiology, clinical presentation, and medical as well as surgical therapy of intracardiac device infections.

Mesh:

Substances:

Year:  2002        PMID: 12092483     DOI: 10.1016/s0891-5520(01)00005-8

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  17 in total

1.  The prevalence of methicillin resistant organisms among pacemaker and defibrillator implant recipients.

Authors:  David J Rodriguez; Aisha Afzal; Rudolph Evonich; David E Haines
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

Review 2.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Cardiac device infections complicated by erosion.

Authors:  Vivian Tsai; Henry Chen; Henry Hsia; Paul Zei; Paul Wang; Amin Al-Ahmad
Journal:  J Interv Card Electrophysiol       Date:  2007-08-01       Impact factor: 1.900

4.  Inhibition of Staphylococcus aureus biofilms by a novel antibacterial envelope for use with implantable cardiac devices.

Authors:  Alessandra Agostinho; Garth James; Oussama Wazni; Mark Citron; Bruce D Wilkoff
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

5.  Complications of native and prosthetic valve infective endocarditis: update in 2006.

Authors:  Ignasi Anguera; Ana del Río; Asunción Moreno; Carlos Paré; Carlos A Mestres; José M Miró
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 6.  Aspergillus fumigatus pacemaker lead endocarditis: a case report and review of the literature.

Authors:  R Leong; Brian R Gannon; Tim J Childs; Phillip A Isotalo; Hoshiar Abdollah
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

7.  Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented.

Authors:  Natividad Benito; Juan M Pericas; Mercè Gurguí; Carlos A Mestres; Francesc Marco; Asunción Moreno; Juan P Horcajada; José M Miró
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

8.  The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).

Authors:  Kathy A Hodgkinson; Patrick S Parfrey; Anne S Bassett; Christine Kupprion; Jörg Drenckhahn; Mark W Norman; Ludwig Thierfelder; Susan N Stuckless; Elizabeth L Dicks; William J McKenna; Sean P Connors
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

9.  Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms.

Authors:  Martin E. Stryjewski; Vivian H. Chu; Christopher H. Cabell; Vance G. Fowler
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

10.  Medical treatment of endocarditis.

Authors:  Elias Abrutyn; Christopher H Cabell; Vance G Fowler; Bruno Hoen; José M Miro; Carlos A Mestres; Daniel J Sexton; G Ralph Corey
Journal:  Curr Infect Dis Rep       Date:  2007-07       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.